Brain changes in post-COVID fatigue overlap with MS
By MS Buddy ·
Summarized from EClinicalMedicine, Apr 2023 · PubMed. AI-generated summary. Not medical advice.
Observational study · people after COVID-19, people with MS, and healthy volunteers
Research by Josephine Heine, Carsten Finke and 14 colleagues at Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin and Humboldt-Universität zu Berlin in Germany.
Do brain changes in post-COVID fatigue overlap with those seen in MS?
Key Takeaway
People with lasting fatigue after COVID-19 had brain changes that overlapped with changes seen in people with MS.

What They Found
Brain scans showed changes in areas involved in movement and thinking among people with lasting fatigue after COVID-19. Some changes overlapped with more widespread changes seen in people with MS and fatigue. Certain scan findings were linked to worse fatigue, daytime sleepiness, and trouble with daily life. Changes in brain shape and size were linked to poorer short-term memory. Worse sleep and more signs of depression were linked to worse fatigue, but the severity of the earlier COVID-19 illness was not.
Who Should Care and Why
The study compared people with lasting symptoms after COVID-19, people with MS and fatigue, and healthy volunteers. The MS group served as a comparison, not as the main group being studied. The overlap in brain scans may interest people with MS who experience fatigue. The study also examined memory, sleep, and mood in the post-COVID group. Its findings about what was linked to fatigue came from people after COVID-19, not from the MS group.
Important Considerations
You should know this was an observational study, so it cannot show that brain changes caused fatigue. Researchers recruited 50 people after COVID-19 and included 47 people with MS and fatigue. The abstract does not give the number of healthy volunteers, so the full study size is unclear.
AI-generated summary — for informational purposes only, not medical advice
Read the original abstract
Published in EClinicalMedicine by et al.. Reproduced from the PubMed record.
Post-COVID syndrome is a severe long-term complication of COVID-19. Although fatigue and cognitive complaints are the most prominent symptoms, it is unclear whether they have structural correlates in the brain. We therefore explored the clinical characteristics of post-COVID fatigue, describe associated structural imaging changes, and determine what influences fatigue severity. We prospectively recruited 50 patients from neurological post-COVID outpatient clinics (age 18-69 years, 39f/8m) and matched non-COVID healthy controls between April 15 and December 31, 2021. Assessments included diffusion and volumetric MR imaging, neuropsychiatric, and cognitive testing. At 7.5 months (median, IQR 6.5-9.2) after the acute SARS-CoV-2 infection, moderate or severe fatigue was identified in 47/50 patients with post-COVID syndrome who were included in the analyses. As a clinical control group, we included 47 matched multiple sclerosis patients with fatigue. Our diffusion imaging analyses revealed aberrant fractional anisotropy of the thalamus. Diffusion markers correlated with fatigue severity, such as physical fatigue, fatigue-related impairment in everyday life (Bell score) and daytime sleepiness. Moreover, we observed shape deformations and decreased volumes of the left thalamus, putamen, and pallidum. These overlapped with the more extensive subcortical changes in MS and were associated with impaired short-term memory. While fatigue severity was not related to COVID-19 disease courses (6/47 hospitalised, 2/47 with ICU treatment), post-acute sleep quality and depressiveness emerged as associated factors and were accompanied by increased levels of anxiety and daytime sleepiness. Characteristic structural imaging changes of the thalamus and basal ganglia underlie the persistent fatigue experienced by patients with post-COVID syndrome. Evidence for pathological changes to these subcortical motor and cognitive hubs provides a key to the understanding of post-COVID fatigue and related neuropsychiatric complications. Deutsche Forschungsgemeinschaft (DFG) and German Ministry of Education and Research (BMBF).
Categories
Explore more research
Related MS research

11/17/2026
A review suggests MS fatigue may reflect extra effort to control movement and incomplete recovery af
Read More
11/16/2026
Computer studies found MS fatigue surveys can give similar group results but different individual sc
Read More
11/17/2026
A review found exercise, therapy focused on thoughts and behavior, and self-management programs show
Read More
11/17/2026
Donated MS brain tissue showed damage in a vision hub. Mouse findings linked local immune cell activ
Read More
1/1/2026
A study of 318 people with MS linked lower thinking test scores to more sexual difficulties, with th
Read More
11/14/2026
In a review of records for 173 people taking Mavenclad for MS, most had no relapses over two years.
Read MoreNot all studies carry the same weight: sample size, study design and whether results were replicated all matter. The credibility score above reflects the journal, and the original paper is linked under More Details. Read how MS Buddy selects and scores research, and talk to your MS care team before acting on any study.
